Infinity Pharmaceuticals Received A Delisting Determination Letter From Nasdaq Stating That The Company's Stock Will Be Suspended On September 14, Unless It Requests A Review Of This Decision
Infinity Pharmaceuticals Received A Delisting Determination Letter From Nasdaq Stating That The Company's Stock Will Be Suspended On September 14, Unless It Requests A Review Of This Decision
Infinity Pharmicals收到了納斯達克的退市決定信，稱除非要求對該決定進行審查，否則該公司的股票將於9月14日停牌
The Company Does Not Plan To Request A Review Of The Panel's Decision
該公司不打算要求對小組的決定進行復審
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。